Biocodex secures rights to Batten-1 and TX01 in agreement worth up to €173 million THX Pharma and Biocodex have entered a strategic licensing agreement covering three rare diseases, with Biocodex ...

GENTILLY, France--(BUSINESS WIRE)--THX Pharma (Theranexus) and Biocodex, an independent international pharmaceutical group, today announced the execution of a strategic licensing agreement to advance ...

Biocodex has acquired two licenses from THX Pharma to develop and commercialize Batten-1 worldwide and TX01 in the United States and Canada. The total deal value is up to €173 million, including a €12 ...

An epic account of how three demigod directors, in pursuit of indie freedom, redefined American film-making ...

Amid Teddi Mellencamp’s ongoing battle with stage 4 melanoma, she shared she was recently hospitalized for contracting Stevens-Johnson’s syndrome, a rare, life-threatening illness.

The latest batch of 3.5 million documents unsealed by the U.S. Department of Justice shows how V.I. government officials ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

Bhad Bhabie—who rose to fame on Dr. Phil in 2016—shared that she received “bad news” about her health amid her ongoing cancer battle.

The S&P 500 Rule of 20 score hits 32.2 as AI productivity shifts baseline P/E ratios and inflation, signaling higher returns.